Korro Bio, Inc. Tax Credit Carryforward, Amount
Korro Bio, Inc. (KRRO) had Tax Credit Carryforward, Amount of $28.04 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes
us-gaap:TaxCreditCarryforwardAmount · last filed 2026-03-12
- 2025-12-31: Tax Credit Carryforward, Amount $28.04M.
- 2024-12-31: Tax Credit Carryforward, Amount $26.41M.
- 2023-12-31: Tax Credit Carryforward, Amount $22.47M.
- 2022-12-31: Tax Credit Carryforward, Amount $5.48M.
| Period end | Tax Credit Carryforward, Amount |
|---|---|
| 2025-12-31 | $28.04M 10-K · filed 2026-03-12 |
| 2024-12-31 | $26.41M 10-K · filed 2026-03-12 |
| 2023-12-31 | $22.47M 10-K · filed 2025-03-18 |
| 2022-12-31 | $5.48M 10-K · filed 2024-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |